Catalyst Wire Dossier Catalyst Wire Dossier

Brimonidine Purite 0.15%

brimonidine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Brimonidine Purite 0.15%, covering 2007-06-01 to 2007-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost [Phase 4]

See pricing